Pacira Biosciences: H.C. Wainwright cuts to neutral rating
PCRX•H.C. Wainwright cut its rating on Pacira Biosciences to neutral.
Related News
Onterris, Inc. target price cut to $25 from $29
ONT•
Slovakia considering options for supplies after ban on Russian gas takes effect, minister says
UNG•
T-Mobile: Scotiabank cuts target price to $212 from $217
TMUS•
CaixaBank-Google Cloud agreement extends collaboration until 2033
GOOGL•
Delta Air Lines Q3 revenue rises 21% on strong travel demand
DAL•